The Military’s Testosterone Testing Policy: A Complex Medical and Ethical Quandary

(SeaPRwire) –   By: Dr. Michael Thompson

I’m Dr. Michael Thompson, a practicing urologist with over 20 years of experience. I’ve seen firsthand the impact of hormonal changes on men’s health, and the military’s new testosterone testing policy has me deeply concerned.

On July 15, 2026, U.S. Defense Secretary Pete Hegseth announced that all service members aged 30 and older must test their testosterone levels annually, with younger members having the option to do so as well. Service members found with “testosterone deficiency” can opt for testosterone replacement therapy (TRT). Hegseth claims this initiative is about restoring and optimizing natural capabilities, not artificial enhancement.

However, the medical community is divided. Many doctors, including myself, question the wisdom of testing asymptomatic individuals. Medical guidelines generally recommend testing only when there are signs or symptoms of deficiency, like low libido, erectile dysfunction, or anemia, or in high-risk medical conditions. The American Urological Association and the Endocrine Society don’t support routine screening, and Hegseth’s recommendation goes against these guidelines.

Take, for example, a 35-year-old service member with no symptoms. Testing him might show a “deficiency,” but it could be a normal part of the natural decline in testosterone that many men experience starting in their late 30s. Subjecting him to unnecessary tests and potential treatment could have unforeseen consequences.

TRT itself has significant side effects. It can stall sperm production, leading to infertility, and increase the risk of blood clots, acne, breast tenderness, and irritability. It’s also typically a long-term or lifelong treatment. Hegseth didn’t mention these side effects or the long-term nature of the treatment in his announcement.

I always counsel my patients about the risks and benefits of TRT. For those interested in maintaining fertility, it’s often not a good option. But for some symptomatic individuals, it can be life-changing. However, it must be done properly, with a full understanding of the implications.

Dr. Mohit Khera of Baylor College of Medicine supports screening, but he too is worried about inappropriate use of TRT. He wouldn’t treat someone without symptoms or with normal testosterone levels, as they could be stuck on the treatment for life. He believes in helping those who are truly low and symptomatic.

The military environment, with its stress and rigors, does put service members at increased risk of low testosterone. Low testosterone is a common feature of Operator Syndrome, a medical phenomenon unique to the military that doctors are still trying to fully understand. Testing at a younger age could provide a baseline, allowing for better monitoring of changes over time. But this also raises the question of how to handle the results appropriately.

In recent years, TRT has become popular among men seeking to optimize their health, including influencers and celebrities. HHS is even considering removing limits on its use in men with age-related low testosterone and revising warning labels. Currently, TRT products in the U.S. are only FDA-approved for men with specific medical conditions related to low testosterone.

This new policy has far-reaching implications. It not only affects the health of individual service members but also sets a precedent. If the military can mandate testosterone testing, what’s next? Could other industries start similar programs? It also forces us to reevaluate our understanding of normal testosterone levels and the appropriate use of medical treatments.

We need to ensure that any decisions regarding TRT are made with the patient’s best interests at heart, based on a full understanding of the risks and benefits. The military should work closely with medical professionals to develop clear guidelines on who should be tested, how the results should be interpreted, and when TRT is truly necessary. Otherwise, we could be opening a Pandora’s box of potential health problems for our service members.
Author bio: Dr. Michael Thompson, an experienced urologist, dedicated to men’s health and understanding the implications of medical policies.